BRCA1 and BRCA2 germline mutations predispose to develop breast and ovarian cancer and also increases the risk to develop other cancer types including pancreatic cancer, prostate cancer, and melanoma [27–29]. This evidence concerns the gene BRCA1 and prostate cancer.